Elicit Enters Pharma Target Screening
elicitorg · x · 2026-07-18
Orion Pharma is integrating Elicit into early-stage drug discovery decisions, specifically for target prioritization. The Elicit team notes that tasks previously taking scientists weeks to manually search, read, and synthesize literature can now be completed faster and cover a broader research scope.
The post mentions that Orion started using Elicit for Reports and Systematic Literature Reviews, later expanding into more workflows following the release of Research Agent. Client feedback indicates that what used to be a "paper by paper" process now takes less time, enabling the same team to evaluate more targets and make more confident go/no-go decisions.
Related event: Orion Pharma Brings Elicit Into Early Drug Research(3 posts)→
More from Companies & People
- IIT Madras Launches EdTech Tulna Standards for AI-Powered Learning Products — ravi_iitm · 2026-09-11
- Warp's six non-engineering teams all run on Linear and Claude Code — mon__lim · 2026-09-11
- Anthropic Insiders: Not Everyone at the Lab Believes in High p(doom) — anpaure · 2026-09-11
- Lumara AI Film Festival Comes to NYC Oct 26, Top AI Filmmakers to Compete — 0xAllen_ · 2026-09-11
- X drama: Anthropic researchers accused of spying on academic customers and racing them to results — basedjensen · 2026-09-11
- Investor argues Palantir-Nvidia partnership should slash Anthropic's IPO valuation — pdamodaran · 2026-09-11